- RSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, according to the CDC.The safety and efficacy data from the trial will be published in a peer-reviewed journal, according to the company.RSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, according to the Centers for Disease Control and Prevention.The U.S. suffered an unusually severe RSV season in the fall among children and older adults as the public largely stopped practicing public health measures implemented in response to the Covid-19 pandemic, such as masking and social distancing.The Covid vaccine turned Moderna into a global name and delivered windfall profits, but it remains the company's only commercially available product and demand is fading."